MAHLY
Price
$15.35
Change
-$0.66 (-4.12%)
Updated
Jul 8 closing price
Capitalization
3.69B
MEPDF
Price
$15.90
Change
-$0.35 (-2.15%)
Updated
Jul 7 closing price
Capitalization
3.69B
Interact to see
Advertisement

MAHLY vs MEPDF

Header iconMAHLY vs MEPDF Comparison
Open Charts MAHLY vs MEPDFBanner chart's image
Medipal Holdings
Price$15.35
Change-$0.66 (-4.12%)
Volume$113
Capitalization3.69B
Medipal Holdings
Price$15.90
Change-$0.35 (-2.15%)
Volume$100
Capitalization3.69B
MAHLY vs MEPDF Comparison Chart in %
Loading...
MAHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MEPDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MAHLY vs. MEPDF commentary
Jul 10, 2025

To understand the difference between Medipal Holdings Corporation - ADR (MAHLY) vs. Medipal Holdings Corporation (MEPDF) it is enough to know the definitions of ADR

ADR - American depositary receipt (ADR) is a certificate issued by a U.S. depositary bank representing a specified number of shares (often 1 share) of a foreign company's stock. ADRs are denominated in U.S. dollars and trade on U.S. stock markets and OTC depending on the ADRs classification.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 10, 2025
Stock price -- (MAHLY: $15.35 vs. MEPDF: $15.90)
Brand notoriety: MAHLY and MEPDF are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: MAHLY: 4% vs. MEPDF: 14%
Market capitalization -- MAHLY: $3.69B vs. MEPDF: $3.69B
MAHLY [@Medical Distributors] is valued at $3.69B. MEPDF’s [@Medical Distributors] market capitalization is $3.69B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MAHLY’s FA Score shows that 0 FA rating(s) are green whileMEPDF’s FA Score has 0 green FA rating(s).

  • MAHLY’s FA Score: 0 green, 5 red.
  • MEPDF’s FA Score: 0 green, 5 red.
According to our system of comparison, MEPDF is a better buy in the long-term than MAHLY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MAHLY’s TA Score shows that 2 TA indicator(s) are bullish while MEPDF’s TA Score has 3 bullish TA indicator(s).

  • MAHLY’s TA Score: 2 bullish, 5 bearish.
  • MEPDF’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, MEPDF is a better buy in the short-term than MAHLY.

Price Growth

MAHLY (@Medical Distributors) experienced а -4.12% price change this week, while MEPDF (@Medical Distributors) price change was -2.15% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +1.57%. For the same industry, the average monthly price growth was +7.33%, and the average quarterly price growth was +3.72%.

Reported Earning Dates

MAHLY is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Medical Distributors (+1.57% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MAHLY($3.69B) and MEPDF($3.69B) have the same market capitalization . MAHLY has higher P/E ratio than MEPDF: MAHLY (13.48) vs MEPDF (12.29). MEPDF YTD gains are higher at: 20.091 vs. MAHLY (-4.510). MAHLY (74B) and MEPDF (74B) have comparable annual earnings (EBITDA) . MAHLY (252B) and MEPDF (252B) have equal amount of cash in the bank . MAHLY (30B) and MEPDF (30B) have identical debt. MAHLY (3.35T) and MEPDF (3.35T) have equivalent revenues.
MAHLYMEPDFMAHLY / MEPDF
Capitalization3.69B3.69B100%
EBITDA74B74B100%
Gain YTD-4.51020.091-22%
P/E Ratio13.4812.29110%
Revenue3.35T3.35T100%
Total Cash252B252B100%
Total Debt30B30B100%
FUNDAMENTALS RATINGS
MAHLY vs MEPDF: Fundamental Ratings
MAHLY
MEPDF
OUTLOOK RATING
1..100
3897
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
87
Overvalued
PROFIT vs RISK RATING
1..100
10048
SMR RATING
1..100
4141
PRICE GROWTH RATING
1..100
5258
P/E GROWTH RATING
1..100
6344
SEASONALITY SCORE
1..100
65n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MAHLY's Valuation (86) in the null industry is in the same range as MEPDF (87). This means that MAHLY’s stock grew similarly to MEPDF’s over the last 12 months.

MEPDF's Profit vs Risk Rating (48) in the null industry is somewhat better than the same rating for MAHLY (100). This means that MEPDF’s stock grew somewhat faster than MAHLY’s over the last 12 months.

MEPDF's SMR Rating (41) in the null industry is in the same range as MAHLY (41). This means that MEPDF’s stock grew similarly to MAHLY’s over the last 12 months.

MAHLY's Price Growth Rating (52) in the null industry is in the same range as MEPDF (58). This means that MAHLY’s stock grew similarly to MEPDF’s over the last 12 months.

MEPDF's P/E Growth Rating (44) in the null industry is in the same range as MAHLY (63). This means that MEPDF’s stock grew similarly to MAHLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MAHLYMEPDF
RSI
ODDS (%)
Bearish Trend 2 days ago
50%
Bullish Trend 2 days ago
33%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
41%
Bullish Trend 7 days ago
17%
Momentum
ODDS (%)
Bullish Trend 2 days ago
31%
Bearish Trend 2 days ago
8%
MACD
ODDS (%)
Bullish Trend 2 days ago
28%
Bearish Trend 2 days ago
38%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
36%
N/A
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
34%
Bearish Trend 2 days ago
9%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
61%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
31%
Bullish Trend 2 days ago
16%
View a ticker or compare two or three
Interact to see
Advertisement
MAHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MEPDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MFEBX51.51N/A
N/A
MFS Value B
AGCSX20.54N/A
N/A
American Century Global Small Cap I
MXSFX8.22N/A
N/A
Empower Real Estate Index Instl
ABIZX23.46N/A
N/A
AMG River Road Mid Cap Value Z
JLPYX22.73-0.06
-0.26%
JPMorgan US Large Cap Core Plus R6

MAHLY and

Correlation & Price change

A.I.dvisor tells us that MAHLY and ZYXI have been poorly correlated (+5% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MAHLY and ZYXI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAHLY
1D Price
Change %
MAHLY100%
-4.12%
ZYXI - MAHLY
5%
Poorly correlated
-3.19%
PDRX - MAHLY
2%
Poorly correlated
N/A
SHPMF - MAHLY
2%
Poorly correlated
N/A
ARRJF - MAHLY
2%
Poorly correlated
N/A
COSM - MAHLY
2%
Poorly correlated
+3.28%
More

MEPDF and

Correlation & Price change

A.I.dvisor tells us that MEPDF and PDRX have been poorly correlated (+0% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MEPDF and PDRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEPDF
1D Price
Change %
MEPDF100%
N/A
PDRX - MEPDF
0%
Poorly correlated
N/A
ARRJF - MEPDF
0%
Poorly correlated
N/A
MAHLY - MEPDF
0%
Poorly correlated
-4.12%
NSVGF - MEPDF
0%
Poorly correlated
N/A
COSM - MEPDF
-1%
Poorly correlated
+3.28%
More